IDX Stock Overview A healthcare services company, engages in the provision of diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Integral Diagnostics Limited Competitors Price History & Performance
Summary of share price highs, lows and changes for Integral Diagnostics Historical stock prices Current Share Price AU$2.97 52 Week High AU$3.18 52 Week Low AU$1.83 Beta 0.67 1 Month Change -1.33% 3 Month Change -3.26% 1 Year Change 58.82% 3 Year Change -33.93% 5 Year Change -23.45% Change since IPO 56.32%
Recent News & Updates
High number of new directors Jan 01
Integral Diagnostics Limited Announces Board Appointments Dec 20
Integral Diagnostics Limited (ASX:IDX) completed the acquisition of Capitol Health Limited (ASX:CAJ). Dec 12 Integral Diagnostics Limited to Report Fiscal Year 2025 Results on Aug 26, 2025
Full year 2024 earnings released: AU$0.26 loss per share (vs AU$0.11 profit in FY 2023) Aug 29
Integral Diagnostics Limited (ASX:IDX) agreed to acquire Capitol Health Limited (ASX:CAJ) for approximately AUD 350 million. Jun 19 See more updates
High number of new directors Jan 01
Integral Diagnostics Limited Announces Board Appointments Dec 20
Integral Diagnostics Limited (ASX:IDX) completed the acquisition of Capitol Health Limited (ASX:CAJ). Dec 12 Integral Diagnostics Limited to Report Fiscal Year 2025 Results on Aug 26, 2025
Full year 2024 earnings released: AU$0.26 loss per share (vs AU$0.11 profit in FY 2023) Aug 29
Integral Diagnostics Limited (ASX:IDX) agreed to acquire Capitol Health Limited (ASX:CAJ) for approximately AUD 350 million. Jun 19 Integral Diagnostics Limited (ASX:IDX) agreed to acquire Capitol Health Limited (ASX:CAJ) for approximately AUD 350 million. Jun 18
First half dividend of AU$0.025 announced Feb 22
First half 2024 earnings released: AU$0.29 loss per share (vs AU$0.069 profit in 1H 2023) Feb 22
IDX™ Announces Appointment of Scott Paterson as Worldwide CFO Feb 07 Integral Diagnostics Limited, Annual General Meeting, Nov 01, 2024
Integral Diagnostics Limited Announces Change of Company Secretary Dec 12
Independent Non-Executive Director recently bought AU$258k worth of stock Dec 06
Integral Diagnostics Limited Announces Resignation of Helen Kurincic as Director Effective 29 November 2023 Nov 30
Investor sentiment deteriorates as stock falls 27% Nov 03
Integral Diagnostics Limited Appoints Toby Hall as Director Sep 28
Integral Diagnostics Limited Declares Fully Franked Final Dividend for the Six Months Ended June 30, 2023, Payable on October 04, 2023 Sep 25
Full year 2023 earnings released: EPS: AU$0.11 (vs AU$0.07 in FY 2022) Aug 30
Integral Diagnostics Limited Declares Fully Franked Final Dividend, Payable on October 04, 2023 Aug 28
Integral Diagnostics Limited Announces Board Changes Aug 10
Upcoming dividend of AU$0.025 per share at 2.0% yield Feb 23
First half 2023 earnings released: EPS: AU$0.069 (vs AU$0.051 in 1H 2022) Feb 18
Integral Diagnostics Limited Announces Ordinary Dividend for the Six Months Ended December 31, 2022, Payable on April 4, 2023 Feb 18
Now 21% undervalued Feb 17
Integral Diagnostics Limited to Report First Half, 2023 Results on Feb 17, 2023 Feb 16 Integral Diagnostics Limited to Report Fiscal Year 2023 Results on Aug 28, 2023
Independent Non-Executive Director recently bought AU$114k worth of stock Sep 06
Integral Diagnostics Limited Declares Fully Franked Final Dividend for the Year Ended June 30, 2022, Payable on October 5, 2022 Aug 29
Full year 2022 earnings released Aug 29
Investor sentiment improved over the past week Aug 02
Integral Diagnostics Limited Announces Appointment of Andrew Fay as an Independent Non-Executive Director Jul 19
Now 21% undervalued after recent price drop Jul 02
Healius Reportedly Keeps Watching Brief on Integral Diagnostics Jun 07
Integral Diagnostics Limited (ASX:IDX) ) agreed to acquire Exact Radiology Pty Ltd for NZD 33.3 million. May 18 Integral Diagnostics Limited (ASX:IDX) agreed to acquire Exact Radiology Pty Ltd for approximately AUD 39 million. May 12
Executive Director recently bought AU$70k worth of stock Mar 04
First half 2022 earnings: EPS in line with analyst expectations despite revenue beat Feb 25
Integral Diagnostics Limited Announces the Distribution for the Six Months Ended December 31, 2021, Payable on April 4, 2022 Feb 24
Investor sentiment deteriorated over the past week Sep 02
Full year 2021 earnings released: EPS AU$0.16 (vs AU$0.12 in FY 2020) Aug 28
Executive Director has left the company Mar 03
First half 2021 earnings released: EPS AU$0.10 (vs AU$0.062 in 1H 2020) Feb 23
Revenue beats expectations Feb 23 Integral Diagnostics Limited Announces Retirement of Dr. Chien Ho as Executive Director, Effective on March 1, 2021
Integral Diagnostics Limited to Report First Half, 2021 Results on Feb 22, 2021 Feb 02
New 90-day high: AU$4.48 Jan 25
New 90-day high: AU$4.42 Nov 12
Executive Director recently sold AU$266k worth of stock Nov 10
Executive Director recently sold AU$123k worth of stock Sep 26
Integral Diagnostics Limited (ASX:IDX) agreed to acquire Ascot Radiology Limited for NZD 54 million. Sep 15 Integral Diagnostics Limited (ASX:IDX) completed the acquisition of Ascot Radiology Limited. Sep 01
New 90-day high - AU$4.30 Aug 26
Earnings released Aug 25 Shareholder Returns IDX AU Healthcare AU Market 7D 2.1% 3.3% 1.3% 1Y 58.8% -4.2% 9.5%
See full shareholder returns
Return vs Market: IDX exceeded the Australian Market which returned 9.5% over the past year.
Price Volatility Is IDX's price volatile compared to industry and market? IDX volatility IDX Average Weekly Movement 3.7% Healthcare Industry Average Movement 5.4% Market Average Movement 8.0% 10% most volatile stocks in AU Market 16.7% 10% least volatile stocks in AU Market 3.0%
Stable Share Price: IDX has not had significant price volatility in the past 3 months compared to the Australian market.
Volatility Over Time: IDX's weekly volatility (4%) has been stable over the past year.
About the Company Integral Diagnostics Limited, a healthcare services company, engages in the provision of diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. It provides positron emission tomography, magnetic resonance imaging, and other radiology services. The company was founded in 1967 and is headquartered in Melbourne, Australia.
Show more Integral Diagnostics Limited Fundamentals Summary How do Integral Diagnostics's earnings and revenue compare to its market cap? IDX fundamental statistics Market cap AU$697.07m Earnings (TTM ) -AU$60.70m Revenue (TTM ) AU$469.70m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) IDX income statement (TTM ) Revenue AU$469.70m Cost of Revenue AU$317.80m Gross Profit AU$151.90m Other Expenses AU$212.60m Earnings -AU$60.70m
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Feb 25, 2025
Earnings per share (EPS) -0.26 Gross Margin 32.34% Net Profit Margin -12.92% Debt/Equity Ratio 72.8%
How did IDX perform over the long term?
See historical performance and comparison Dividends
1.9% Current Dividend Yield
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2025/01/10 18:11 End of Day Share Price 2025/01/10 00:00 Earnings 2024/06/30 Annual Earnings 2024/06/30
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Integral Diagnostics Limited is covered by 24 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Russell Wright Barclay Pearce Capital Pty Limited Thomas Yeo Barrenjoey Markets Pty Limited Saul Hadassin Barrenjoey Markets Pty Limited
Show 21 more analysts 
